XBiotech Inc.

XBIT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014
Assets
Cash & Equivalents $31.8M $34.3M $91.1M $57.3M
Accounts Receivable — — — —
Inventory — — — —
Total Current Assets $33.3M $36.9M $93.0M $58.1M
Property, Plant & Equipment $29.6M $10.1M $5.9M $3.2M
Goodwill — — — —
Intangible Assets (Excl. Goodwill) — — — —
Total Assets $63.0M $67.1M $109.4M $62.2M
Liabilities
Accounts Payable $1.7M $4.4M $4.8M $1.6M
Total Current Liabilities $2.8M $8.0M $6.3M $3.1M
Long-Term Debt — — — —
Total Liabilities $2.8M $8.0M $6.3M $3.1M
Stockholders' Equity
Retained Earnings $-216.6M $-183.4M $-130.7M $-93.2M
Total Stockholders' Equity $60.2M $59.1M $103.1M $59.0M
← Newer Page 2 of 2 Older →